Affordable Access

Publisher Website

Cytokine mRNA induction by interleukin-1β or tumor necrosis factor αin vitroandin vivo

Brain Research
Publication Date
DOI: 10.1016/j.brainres.2008.05.067
  • Sleep Regulatory Substance
  • Hypothalamus
  • Somatosensory Cortex
  • Interleukin
  • Tumor Necrosis Factor
  • Gaba


Abstract Hypothalamic and cortical mRNA levels for cytokines such as interleukin-1β (IL1β), tumor necrosis factor alpha (TNFα), nerve growth factor (NGF) and brain derived neurotrophic factor (BDNF) are impacted by systemic treatments of IL1β and TNFα. To investigate the time course of the effects of IL1β and TNFα on hypothalamic and cortical cytokine gene expression, we measured mRNA levels for IL1β, TNFα, interleukin-6 (IL-6), interleukin-10 (IL-10), IL1 receptor 1, BDNF, NGF, and glutamate decarboxylase-67 in vitro using hypothalamic and cortical primary cultures. IL1β and TNFα mRNA levels increased significantly in a dose-dependent fashion after exposure to either IL1β or TNFα. IL1β increased IL1β mRNA in both the hypothalamic and cortical cultures after 2–6 h while TNFα mRNA increased significantly within 30 min and continued to rise up to 2–6 h. Most of the other mRNAs showed significant changes independent of dose in vitro. In vivo, intracerebroventricular (icv) injection of IL1β or TNFα also significantly increased IL1β, TNFα and IL6 mRNA levels in the hypothalamus and cortex. IL1β icv, but not TNFα, increased NGF mRNA levels in both these areas. Results support the hypothesis that centrally active doses of IL1β and TNFα enhance their own mRNA levels as well as affect mRNA levels for other neuronal growth factors.

There are no comments yet on this publication. Be the first to share your thoughts.